We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Showcases Latest Innovations in Diagnostic Solutions at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: The Roche exhibit booth at AACC 2022 featured demonstrations of 18 innovative systems (Photo courtesy of Roche)
Image: The Roche exhibit booth at AACC 2022 featured demonstrations of 18 innovative systems (Photo courtesy of Roche)

Roche Diagnostics (Basel, Switzerland) will showcase a cutting-edge interactive and solutions-focused exhibit at the 2022 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo, July 24-28 in Chicago.

The Roche exhibit booth (No. 2002) will feature the latest solutions that can connect laboratory systems, analyze data and drive new efficiencies so labs have more time to focus on delivering better patient care. To address current laboratory challenges, Roche will also introduce the Roche Idea Lab, where experts in areas critical to laboratory success will provide key insights. These areas include a lab’s success in health equity and testing access, staffing pressures, data optimization, and improving clinical outcomes for patients with cardiometabolic, neurodegenerative and infectious diseases. Roche will also present 11 interactive workshops as part of the Idea Lab to share best practices and provide answers on topics that matter most in today’s evolving lab environment.

The Roche exhibit booth will feature demonstrations of 18 innovative systems, including the cobas pro and cobas pure serum work area solutions, the cobas 5800 molecular system and the cobas pulse point-of-care professional glucose management solution. The cobas 5800 system allows labs to improve the productivity of their floor space by running a broad menu of assays from a small footprint, using fully automated and standardized workflows. The cobas 5800 System helps labs by making automation, consolidation, integration and standardization more accessible than ever before. The cobas pulse system is an industry first professional blood glucose management solution with mobile digital health capabilities to help improve patient care. Designed to help improve workflows and change healthcare in favor of cost efficiency and better patient care, the cobas pulse system is the gateway to the future of digital health.
 

Related Links:
Roche Diagnostics 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The real-time multiplex PCR test is set to revolutionize early sepsis detection (Photo courtesy of Shutterstock)

1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens

Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.